PEspeaks

May 25, 2016
We desperately need new anti-infective drugs to avoid life threatening infections. Let’s make that happen by punishing companies who don’t invest in R&D for these specific drugs.
May 24, 2016
Radicals who wield real power at the EMA have gone public with their thinking about the role of regulators in the economic aspects of medicines provision.
May 16, 2016
Pharmaceutical Executive
The industry has much to be optimistic about in 2016. But a look at the winner of our “Anti-Brand of the Year” clarifies how many outside the industry really see it.
May 12, 2016
Election-year activities may stall the passage of biomedical innovation bill in 2016.
May 04, 2016
Pharmaceutical Executive
The Boston biotech cluster proved an ideal setting for Pharm Exec's recent annual Editorial Advisory Board meeting. William Looney reports.
May 03, 2016
From Applied Clinical Trials
Amidst arguments that industry is heading for another economic recession, Moe Alsumidaie reminds us that biopharma has shown resiliency during such times.
Apr 27, 2016
Pharmaceutical Executive
Policymakers seek to limit prescribing while also encouraging innovative R&D.
Apr 26, 2016
Facebook is the number one social-media network for businesses. Peter Houston asks, How can pharma stay relevant in the feed?
Apr 11, 2016
The American College of Physicians has chimed in on the debate surrounding prescription drug costs, offering its views for stemming the escalation.
Apr 01, 2016
In many life situations, it’s difficult to be hopeful. But at SxSW Interactive last month, it was difficult to be pessimistic, writes Bill Drummy.
lorem ipsum